Molecular Characteristics and Prevalence of Viral Hepatitis E in Human Tissue and Cell Donors
University Hospital Ostrava
300 participants
Jan 1, 2022
INTERVENTIONAL
Conditions
Summary
In this study, the researchers want to focus on the prevalence of anti-HEV antibodies by a new generation test, direct detection of HEV RNA, and its genotypic analysis in a group of human tissue and cell donors.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Diagnostic test used to determine antibodies in blood and serum.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06457438